Association Between Depressive Symptoms and Incident Cardiovascular Diseases.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
15 12 2020
Historique:
entrez: 15 12 2020
pubmed: 16 12 2020
medline: 23 1 2021
Statut: ppublish

Résumé

It is uncertain whether depressive symptoms are independently associated with subsequent risk of cardiovascular diseases (CVDs). To characterize the association between depressive symptoms and CVD incidence across the spectrum of lower mood. A pooled analysis of individual-participant data from the Emerging Risk Factors Collaboration (ERFC; 162 036 participants; 21 cohorts; baseline surveys, 1960-2008; latest follow-up, March 2020) and the UK Biobank (401 219 participants; baseline surveys, 2006-2010; latest follow-up, March 2020). Eligible participants had information about self-reported depressive symptoms and no CVD history at baseline. Depressive symptoms were recorded using validated instruments. ERFC scores were harmonized across studies to a scale representative of the Center for Epidemiological Studies Depression (CES-D) scale (range, 0-60; ≥16 indicates possible depressive disorder). The UK Biobank recorded the 2-item Patient Health Questionnaire 2 (PHQ-2; range, 0-6; ≥3 indicates possible depressive disorder). Primary outcomes were incident fatal or nonfatal coronary heart disease (CHD), stroke, and CVD (composite of the 2). Hazard ratios (HRs) per 1-SD higher log CES-D or PHQ-2 adjusted for age, sex, smoking, and diabetes were reported. Among 162 036 participants from the ERFC (73%, women; mean age at baseline, 63 years [SD, 9 years]), 5078 CHD and 3932 stroke events were recorded (median follow-up, 9.5 years). Associations with CHD, stroke, and CVD were log linear. The HR per 1-SD higher depression score for CHD was 1.07 (95% CI, 1.03-1.11); stroke, 1.05 (95% CI, 1.01-1.10); and CVD, 1.06 (95% CI, 1.04-1.08). The corresponding incidence rates per 10 000 person-years of follow-up in the highest vs the lowest quintile of CES-D score (geometric mean CES-D score, 19 vs 1) were 36.3 vs 29.0 for CHD events, 28.0 vs 24.7 for stroke events, and 62.8 vs 53.5 for CVD events. Among 401 219 participants from the UK Biobank (55% were women, mean age at baseline, 56 years [SD, 8 years]), 4607 CHD and 3253 stroke events were recorded (median follow-up, 8.1 years). The HR per 1-SD higher depression score for CHD was 1.11 (95% CI, 1.08-1.14); stroke, 1.10 (95% CI, 1.06-1.14); and CVD, 1.10 (95% CI, 1.08-1.13). The corresponding incidence rates per 10 000 person-years of follow-up among individuals with PHQ-2 scores of 4 or higher vs 0 were 20.9 vs 14.2 for CHD events, 15.3 vs 10.2 for stroke events, and 36.2 vs 24.5 for CVD events. The magnitude and statistical significance of the HRs were not materially changed after adjustment for additional risk factors. In a pooled analysis of 563 255 participants in 22 cohorts, baseline depressive symptoms were associated with CVD incidence, including at symptom levels lower than the threshold indicative of a depressive disorder. However, the magnitude of associations was modest.

Identifiants

pubmed: 33320224
pii: 2774050
doi: 10.1001/jama.2020.23068
pmc: PMC7739139
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2396-2405

Subventions

Organisme : Medical Research Council
ID : MC_UP_A620_1015
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/13/13/30194
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : P30 DK123704
Pays : United States
Organisme : Medical Research Council
ID : MR/L003120/1
Pays : United Kingdom
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : Medical Research Council
ID : G0601463
Pays : United Kingdom
Organisme : Versus Arthritis
ID : 19583
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12011/2
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Références

J Aging Health. 1993 May;5(2):179-93
pubmed: 10125443
Eur J Epidemiol. 2007;22(12):839-69
pubmed: 17876711
World Psychiatry. 2017 Jun;16(2):163-180
pubmed: 28498599
Int J Epidemiol. 2003 Feb;32(1):1-22
pubmed: 12689998
BMJ. 2012 Jul 31;345:e4933
pubmed: 22849956
PLoS One. 2016 Apr 22;11(4):e0153838
pubmed: 27105076
Eur Heart J. 2020 May 1;41(17):1687-1696
pubmed: 30698764
Circulation. 2014 Mar 25;129(12):1350-69
pubmed: 24566200
JAMA Psychiatry. 2013 Aug;70(8):803-11
pubmed: 23760442
Int J Epidemiol. 1999 Oct;28(5):964-74
pubmed: 10597998
Int J Cardiol. 2015 Feb 1;180:103-10
pubmed: 25438228
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
JAMA. 2011 Sep 21;306(11):1241-9
pubmed: 21934057
Med Care. 2003 Nov;41(11):1284-92
pubmed: 14583691
Medicine (Baltimore). 2016 Feb;95(6):e2815
pubmed: 26871852
Stroke. 2012 Jan;43(1):32-7
pubmed: 22020036
Stat Med. 2004 Jan 15;23(1):93-104
pubmed: 14695642
Eur Heart J. 2006 Dec;27(23):2763-74
pubmed: 17082208
Nat Rev Cardiol. 2017 Mar;14(3):145-155
pubmed: 27853162
PLoS One. 2013 Nov 25;8(11):e75362
pubmed: 24282498
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
J Am Heart Assoc. 2016 Dec 21;5(12):
pubmed: 28003250
J Gerontol B Psychol Sci Soc Sci. 2004 Nov;59(6):P270-7
pubmed: 15576854
Neuropsychiatr Dis Treat. 2014 Dec 18;11:1-14
pubmed: 25565846
Stat Med. 2010 May 30;29(12):1282-97
pubmed: 19408255
Arch Intern Med. 2004 Feb 9;164(3):289-98
pubmed: 14769624
Int J Epidemiol. 2010 Oct;39(5):1345-59
pubmed: 20439481
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Eric L Harshfield (EL)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.

Lisa Pennells (L)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Joseph E Schwartz (JE)

Center for Behavioral Cardiovascular Health, Columbia University Medical Center, New York, New York.
Applied Behavioral Medicine Research Institute, Stony Brook University, Stony Brook, New York.

Peter Willeit (P)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Department of Neurology & Neurosurgery, Medical University of Innsbruck, Innsbruck, Austria.

Stephen Kaptoge (S)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Steven Bell (S)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.

Jonathan A Shaffer (JA)

University of Colorado Denver, Denver.

Thomas Bolton (T)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Sarah Spackman (S)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Sylvia Wassertheil-Smoller (S)

Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.

Frank Kee (F)

Centre for Public Health, Queens University, Belfast, United Kingdom.

Philippe Amouyel (P)

Institut Pasteur de Lille, Lille, France.

Steven J Shea (SJ)

Columbia Field Center, Columbia University, New York, New York.

Lewis H Kuller (LH)

Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania.

Jussi Kauhanen (J)

Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.

E M van Zutphen (EM)

Department of Psychiatry, Amsterdam Public Health Research Institute, Amsterdam UMC at VU University Medical Center, Amsterdam, the Netherlands.
Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam UMC at VU University Medical Center, Amsterdam, the Netherlands.
GGZ inGeest Specialized Mental Health Care, Amsterdam, the Netherlands.

Dan G Blazer (DG)

Department of Psychiatry and Behavioral Sciences, Duke University, Durham, North Carolina.

Harlan Krumholz (H)

Yale School of Medicine, New Haven, Connecticut.

Paul J Nietert (PJ)

Department of Public Health Sciences, Medical University of South Carolina.

Daan Kromhout (D)

Department of Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.

Gail Laughlin (G)

Family Medicine & Public Health, University of California, San Diego.

Lisa Berkman (L)

Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

Robert B Wallace (RB)

Department of Epidemiology, University of Iowa College of Public Health.

Leon A Simons (LA)

Faculty of Medicine, UNSW, Sydney, Australia.

Elaine M Dennison (EM)

MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom.

Elizabeth L M Barr (ELM)

Baker Heart and Diabetes Institute, Melbourne, Australia.

Haakon E Meyer (HE)

Norwegian Institute of Public Health, Oslo, Norway.

Angela M Wood (AM)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

John Danesh (J)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Emanuele Di Angelantonio (E)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Karina W Davidson (KW)

Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH